Vaxneuvance suspension for injection in pre-filled syringe

Licence status
Authorised: 13/12/2021
Active substances
Pneumococcal Polysaccharide Serotype 1 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 4 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 5 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7f, Pneumococcal Polysaccharide Serotype 9V Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 14 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 18C Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 19A Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 19F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 22F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 23F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 33F Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6B Conjugated to CRM197
Dosage Form
Suspension for injection in pre-filled syringe
Licence number
EU/1/21/1591/001-006
Licence holder
Merck Sharp & Dohme BV,

Product documents

Licence information

ATC code
J07AL Pneumococcal vaccines
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
13/12/2021